GSA Capital Partners’s Pulse Biosciences PLSE Stock Holding History

GSA Capital Partners’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$290K	Buy	+10,468	New	+$247K	0.02%	1326
2025 Q2	–	Sell	-10,916	Closed	-$176K	–	2059
2025 Q1	$176K	Buy	+10,916	New	+$203K	0.02%	1420
2024 Q2	–	Sell	-33,018	Closed	-$288K	–	1947
2024 Q1	$288K	Buy	+33,018	New	+$303K	0.02%	1239
2022 Q1	–	Sell	-11,102	Closed	-$164K	–	1733
2021 Q4	$164K	Buy	+11,102	New	+$221K	0.02%	1255
2018 Q4	–	Sell	-12,000	Closed	-$170K	–	1661
2018 Q3	$170K	Buy	+12,000	New	+$170K	0.01%	1510

Other funds holding PLSE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCM

Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

GSA Capital Partners's PLSE Position: Q2 2026 in Review

GSA Capital Partners opened a new position in Pulse Biosciences (PLSE) in Q2 2026: 10,468 shares worth $290K. The stake represents 0.02% of the portfolio and ranks #1326 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in PLSE as recently as Q1 2025.

GSA Capital Partners first reported a position in PLSE in Q3 2018 and has held it in 5 quarters since. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

GSA Capital Partners held 10,468 shares of Pulse Biosciences worth $290K as of Q2 2026.
Pulse Biosciences was a new GSA Capital Partners position in Q2 2026.
Pulse Biosciences made up 0.02% of GSA Capital Partners's portfolio in Q2 2026, its #1326 holding.
GSA Capital Partners first reported a position in Pulse Biosciences in Q3 2018 and has held it in 5 quarters since.
106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.